Home computer eye exercises for older adults with mild cognitive impairment
Tests nLIFE EyeFitness home exercises in older people with mild cognitive impairment.
Key facts
- Who runs it
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Where
- Italy1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Personalized Medicine in the Elderly With Vision Impairment and Mild Cognitive Impairment
- Status
- Not yet recruiting
- People taking part
- 24 people, planned
- Started
- 1 May 2025
- Expected to end
- 28 Feb 2027
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- nLIFE EyeFitness
- Record updated
- 24 April 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people aged 60 to 75 with amnestic mild cognitive impairment (aMCI), a mild memory problem. It tests home computer training for vision and thinking with nLIFE EyeFitness.
- Age
- 60 to 75 years
- Sex
- All sexes
- Disease stage
- Diagnosis of amnestic mild cognitive impairment (aMCI).
Main reasons for not taking part
- History of dementia
- Diabetes mellitus or high blood pressure that is not under control
- Diagnosis of major depression
- Glaucoma or age-related macular degeneration
- Clouding in the eye or retina and vitreous problems that block a correct eye check
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Patients aged ≥ 60 years with a diagnosis of aMCI
- Signing of informed consent
Who cannot take part
- History of dementia
- Diabetes mellitus
- Uncontrolled hypertension
- • Failure to obtain informed consent
- Age <60 years
- Age-related macular degeneration
- Diagnosis of major depression
- Glaucoma
- Media opacity and vitreoretinal pathologies that may preclude a correct evaluation
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 60 and 75 years old?
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Globally, approximately 55 million people suffer from dementia, and 60-70% of cases are due to Alzheimer's disease (AD). Increasing scientific evidence highlights that the pathological changes underlying AD and other forms of dementia begin long before the onset of symptoms. Mild cognitive impairment (MCI) is a clinical condition that in people over 65 shows a prevalence ranging from 3% to 22%. The characteristics of MCI are the presence of a subjective memory disorder and a reduced ability to learn new information with normal general cognitive functioning, normal ability to perform daily activities and the absence of other conditions, such as depression, that could justify the memory disorder. Currently, the diagnosis of MCI is based exclusively on clinical evaluation, including neuropsychological tests.
Read full original descriptionShow less
Currently, there are no therapies available to prevent and/or treat dementia and the options for intervention are represented by treatments such as physical exercise and cognitive treatment. These practices refer to the concept of cognitive reserve. Computerized cognitive training (CCT) is characterized by being a personalized intervention, allows multi-domain training and increases the cognitive processes of patients with MCI. The National Low Vision Center has been using a software called nLIFE EyeFitness for several years, certified as a Class I Medical device. It allows you to carry out individualized rehabilitation exercises at home, using your own PC or tablet, with monitoring by the Center's operators. The exercises currently present stimulate attention, short-term visual memory, reaction time, executive function, working memory and, therefore, also appear suitable for stimulating subjects with MCI.
The 2 groups in the trial
- SperimentalTreatment being tested
All patients will undergo: * Standardized battery of tests for the diagnosis of cognitive decline corresponding to the BDM (Battery for Mental Deterioration * Global assessment measure of cognitive status (Minimal Mental State Examination - MMSE) * Complete eye examination * Tonometry * Visual acuity for distance (ETDRS) and near (MNRead) * Reading speed (IrestTEST) * Microperimetry * Psychological evaluation * Patients with visual impairment randomized to receive neurovisual rehabilitation treatment will carry out neurosensory rehabilitation remotely.
Treatment: nLIFE EyeFitness
- ControlNo study treatment, for comparison
All patients will undergo: * Standardized battery of tests for the diagnosis of cognitive decline corresponding to the BDM (Battery for Mental Deterioration * Global assessment measure of cognitive status (Minimal Mental State Examination - MMSE) * Complete eye examination * Tonometry * Visual acuity for distance (ETDRS) and near (MNRead) * Reading speed (IrestTEST) * Microperimetry * Psychological evaluation
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Personalized Medicine in the Elderly With Vision Impairment and Mild Cognitive Impairment: Effects of Sensorineural Telerahabilitation
- Plain-language title
- Home computer eye exercises for older adults with mild cognitive impairmentGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT06942728, who can take part
- Record updated
- 24 April 2025